肝功能衰竭患者发生感染性休克的影响因素

Influencing factors for septic shock in patients with liver failure

  • 摘要: 目的 探讨肝功能衰竭患者发生感染性休克的影响因素。方法 选取2018年1月-2019年12月在海南省海口市第三人民医院诊断结果明确为肝功能衰竭并发感染性休克的患者50例作为感染性休克组,按照年龄相差不超过2岁的原则选取同一时段就诊的未发生感染性休克的肝功能衰竭患者50例作为非感染性休克组。收集患者的年龄、性别、患病史、血清免疫球蛋白M(Immunoglobulin M,IgM)和IgG、C-反应蛋白(C-reactive protein,CRP)、甲胎球蛋白(Alpha fetoprotein,AFP)、血乳酸(Blood lactate,LAC)、尿素氮(Urea nitrogen,BUN)、短期内肌酐(Creatinine,Cr)的数据,归纳肝功能衰竭患者发生感染性休克的影响因素,并分析病原菌及其耐药性。结果 感染性休克组Cr、LAC分别为(323.45±123.32)μg/L、(5.48±0.69)mmol/L高于非感染性休克组,IgG、IgA、IgM分别为(26.12±4.36)mg/L、(12.23±1.23)mg/L、(13.25±2.39)mg/L低于非感染性休克组(P<0.05);Cr、IgG、IgM是肝衰竭患者发生感染性休克的影响因素(P<0.05);50例感染患者共检出病原菌102株,其中革兰阴性菌61株占59.80%,以大肠埃希菌为主;革兰阳性菌25株占24.51%,真菌16株占15.69%;大肠埃希菌对氨苄西林、四环素、左氧氟沙星、头孢唑林、头孢他啶、头孢曲松、环丙沙星的耐药性均>50%,对呋喃妥因、厄他培南、亚胺培南较敏感;肺炎克雷伯菌对氨苄西林、头孢唑林、头孢他啶等药物的耐药性较高,对厄他培南的耐药性为0%;金黄色葡萄球菌对氨苄西林的耐药性较高,为90.91%,对呋喃妥因和亚胺培南敏感;屎肠球菌对氨苄西林、左氧氟沙星的耐药性均达到100.00%;白假丝酵母对两性霉素B、氟康唑、卡泊芬净敏感;曲霉菌对氟康唑的耐药性达100.00%,对酮康唑的耐药性为50.00%。结论 肝功能衰竭患者因肝脏受损免疫功能受到影响,病菌感染概率增加,易造成代谢紊乱,如血乳酸,肌酐等指数的异常,使患者有感染性休克的风险。Cr、IgG、IgM是肝衰竭患者发生感染性休克的影响因素。感染病原菌以大肠埃希菌为主,因常用抗菌药物的使用,病原菌对多种药物均产生耐药性,提示临床上应规范合理使用抗菌药物。

     

    Abstract: OBJECTIVE To investigate the influencing factors of septic shock in patients with liver failure. METHODS Totally 50 patients with liver failure complicated with septic shock at the Third People’s Hospital of Haikou City of Hainan Province from Jan. 2018 to Dec. 2019 were selected as the septic shock group, and 50 patients with liver failure who did not develop septic shock at the same period according to the principle that the age difference does not exceed 2 years were selected as non-infectious shock group. The patient's age, sex, medical history, serum immunoglobulin M(IgM), C-reactive protein(CRP), alpha fetoprotein(AFP), blood lactate(Blood lactate, LAC), Urea nitrogen(BUN), short-term Creatinine(Cr) data were collected, the infectious factors of septic shock in patients with liver failure were summarized, and pathogens and their drug resistance were analyzed. RESULTS The Cr and lAC in septic shock group were(323.45±123.32) μg/L and(5.48±0.69) mmol/L respectively, significently higher than those in non-infectious septic shock group. IgG, IgA and IgM were(26.12±4.36) mg/L,(12.23±1.23) mg/L and(13.25±2.39) mg/L, respectively, significently lower than those in non-infectious septic shock group(P<0.05). Cr, IgG and IgM were the influencing factors of septic shock in patients with liver failure(P<0.05). A total of 102 strains of pathogens were detected in 50 infected patients, of which 61 strains of Gram-negative bacteria accounted for 59.80%, mainly Escherichia coli; 25 strains of Gram-positive bacteria accounted for 24.51%, and 16 strains of fungi accounted for 15.69%. The drug resistance of Escherichia coli to ampicillin, tetracycline, levofloxacin, cefazolin, ceftazidime, ceftriaxone, ciprofloxacin were more than 50%, while Escherichia coli were sensitive to nitrofurantoin, ertapenem and imipenem. Klebsiella pneumoniae was highly resistant to drugs such as ampicillin, cefazolin and ceftazidime, and 0% to ertapenem. The resistance of Staphylococcus aureus to ampicillin was 90.91%, and it was sensitive to nitrofurantoin and imipenem. The resistance of Enterococcus faecium to ampicillin and levofloxacin was 100.00%. Candida albicans was sensitive to amphotericin B, fluconazole and carbamazepine. The resistance of Aspergillus to fluconazole and ketoconazole was 100.00% and 50.00%, respectively. CONCLUSION Patients with liver failure were affected by the impaired immune function of the liver, and the probability of bacterial infection increased, which was easy to cause metabolic disorders, such as abnormal indexes such as blood lactic acid and creatinine, ultimately put the patients at risk of septic shock. Multivariate analysis showed that Cr, IgG and IgM were the influencing factors of septic shock in patients with liver failure. The main pathogens of infection are Escherichia coli. Due to the use of commonly used antibiotics, the pathogens were resistant to a variety of drugs, suggesting that the clinical use of antibacterial drugs should be standardized and rational.

     

/

返回文章
返回